GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » Future 3-5Y EPS without NRI Growth Rate

IMTX (Immatics NV) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Mar. 28, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Immatics NV Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Immatics NV's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Immatics NV's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Immatics NV's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immatics NV's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immatics NV's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Immatics NV's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Immatics NV  (NAS:IMTX) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Immatics NV Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Immatics NV's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Immatics NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XERS MNMD PGEN ANAB ABSI MGTX TECX ORIC MRVI OMER VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
4A3:Germany
Address
Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Website
https://www.immatics.com
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.